Domestic companies were divided into two groups over the strategy for Januvia generics

Last month, the product attracted the most interests of the industry after enforcement of the Patent Linkage System was the diabetes treatment ‘Januvia.’

In order to launch the product ahead of other in the annually over KRW 100 billion blockbuster-level market, approximately 30 lawsuits were filed before the enforcement. Along with the interests, domestic pharmaceutical companies are pouring ...